get a key
steadybase-$ company ANEB
account_id none on file
legal_name Anebulo Pharmaceuticals, Inc.
ticker ANEB
cik 1815974
domain anebulo.com
entry_point_account_id none on file
name Anebulo Pharmaceuticals Inc.
exchange OTC
sector Health Care
calls 0 filings 8 executives 1 family 0
why_nownone on file
callsnone on file
filings
associated with research and development activities of consultants, including travel expense; ● other third-party expenses directly attributable to the development of our product candidates; and ● amortization expense for future asset purchases used in research and development activities.

filing / Feb 12, 2026 / receipt

Office Lease, Manufacturing Contract and CRO Contract We manage our business operations from our principal executive office in Lakeway, Texas, in leased space under a sublease with a related party for approximately $400 per month.

filing / Feb 12, 2026 / receipt

associated with research and development activities of consultants, including travel expense; ● other third-party expenses directly attributable to the development of our product candidates; and ● amortization expense for asset purchases used in research and development activities.

filing / Sep 29, 2025 / receipt

George was appointed as our part time Chief Financial Officer on September 28, 2023. Pursuant to his offer letter, we compensated

filing / Sep 29, 2025 / receipt

Such cost containment programs include restrictions on coverage and reimbursement, price controls and requirements to substitute branded prescription drugs with generic products.

filing / Sep 29, 2025 / receipt

We believe our present office space is adequate for our current operations and for near-term planned expansion. We recorded rent expense of approximately $4,800 for the fiscal years ended June 30, 2025 and 2024.

filing / Sep 29, 2025 / receipt

Office Lease, Manufacturing Contract and CRO Contract We manage our business operations from our principal executive office in Lakeway, Texas, in leased space under a sublease with a related party for approximately $400 per month.

filing / Sep 29, 2025 / receipt

appointed Richard Anthony Cunningham (55), the Company’s current Chief Executive Officer , to serve as the Company’s Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer, effective as of P1D September 30, 2025.

filing / Sep 29, 2025 / receipt

executives
Richard (Richie) Anthony Cunningham Chief Executive Officer - receipt
familynone on file
upcomingnone on file
changes
2023-10-06 Chief Executive Officer, appointed sec_8k
2023-09-05 Acting Chief Financial Officer, departed sec_8k
2023-03-08 Acting Chief Financial Officer, appointed sec_8k
mcp_package_hint
steadybase-$